To present the pioneering concept, Peer and his team encoded the anti-inflammatory protein interleukin-10 into mRNA and ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered biologics.

An ustekinumab biosimilar to Stelara launched in France, completing its rollout across 5 major European markets and paving ...

Overall, the use of 5-aminosalicylic acid (5-ASA) in combination with ustekinumab (UST) did not provide a significant benefit ...

Amongst the drug classes used within the dermatology space, interleukin (IL) inhibitors were highlighted as a major growth driver. Additional insights into pipeline development indicate an exciting ...